logo

Cellular Biomedicine Group Inc. (CBMG)



Trade CBMG now with
  Date
  Headline
1/17/2019 6:05:12 AM CBMG: AlloJoin Therapy For KOA Becomes First Stem Cell Drug Application Approved In China For Phase II Clinical Trials
1/8/2019 7:42:54 PM Cellular Biomedicine Group Initiates Patient Recruitment For Clinical Trial In Anti-BCMA CAR-T Therapy
12/18/2018 7:31:47 AM Cellular Biomedicine Group Appoints Stephan Grupp As Member Of Scientific Advisory Board
11/6/2018 7:09:14 AM Cellular Biomedicine Group Q3 Loss/shr $0.72 Vs. Loss/shr $0.43 Last Year
9/27/2018 7:37:09 AM Cellular Biomedicine Enters Into Strategic Licensing And Collaboration Deal With A Global Leader In CAR-T Cell Therapy
8/8/2018 7:34:14 AM Cellular Biomedicine Group Q2 Net Loss Allocable To Common Stock Holders $9.2 Mln
5/8/2018 6:08:49 AM Cellular Biomedicine Q1 Net Loss Allocable To Common Stock Holders $8.5 Mln Vs Loss $6.2 Mln Last Year
3/16/2018 7:04:12 AM Cellular Biomedicine Announces Positive 48-Week Clinical Data Of AlloJoin HaMPC And KOA China Phase I Trial